← Leaderboards
Aron H Lichtman
Virginia Commonwealth University
$10,846,349
Attributed
$15,684,163
Total exposure
14
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2005–23$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$20,011,003 · 15
By mechanism
P01$8,932,310 · 6
R01$8,596,522 · 5
P30$2,248,604 · 2
R21$176,597 · 1
R25$56,970 · 1
Top collaborators
- Benjamin F Cravatt6 shared
- Kurt Francis Hauser6 shared
- Dai Lu6 shared
- Dana E Selley6 shared
- Laura J Sim-Selley6 shared
- Debra A Kendall5 shared
- Jenny L. Wiley2 shared
- Steven G. Kinsey1 shared
Most similar at Virginia Commonwealth University
Same institution · by research overlap
- Jenny L. Wiley$18,479,501
- Matthew Sean Halquist$1,629,321
- Peter Tiendung Nguyen$153,748
- Billy R Martin$6,338,294
- Raj Razdan$4,785,682
Others in their field
Top investigators on “Receptor”
- Barton F Haynes · Duke University$182,835,224
- James C. Paulson · Scripps Research Institute$84,068,192
- Asrar B. Malik · University Of Illinois At Chicago$55,280,031
- Anthony O Caggiano · Cognition Therapeutics, Inc.$49,563,751
- Robert J Coffey · Vanderbilt University$48,115,270
- Robert H Vonderheide · University Of Pennsylvania$48,030,034
Research focus
ReceptorResponsePainAnandamideEndocannabinoidsCannabinoidsPharmaceutical PreparationsMouse ModelIn VivoBehavioralChronicBrainBehaviorBrain RegionEnzymes2-ArachidonylglycerolMediatingInterestGeneticPlayAnimalsDrug AbuseInhibitor/AntagonistDependence
Grant awards (60)
Mutant Mouse/Viral Vector Core$305,774
P30 · FY2023 · DA · contact PI
Mutant Mouse/Viral Vector Core$305,774
P30 · FY2022 · DA · contact PI
Mutant Mouse/Viral Vector Core$305,774
P30 · FY2021 · DA · contact PI
CB1 Allosteric Modulators: Molecular, Cellular and In Vivo Pharmacology$470,413
R01 · FY2020 · DA · contact PI
Mutant Mouse/Viral Vector Core$305,774
P30 · FY2020 · DA · contact PI
S1P Receptor Mechanisms in Neuropathic Pain$541,645
R01 · FY2019 · NS
CB1 Allosteric Modulators: Molecular, Cellular and In Vivo Pharmacology$478,136
R01 · FY2019 · DA
Mutant Mouse/Viral Vector Core$305,733
P30 · FY2019 · DA · contact PI
S1P Receptor Mechanisms in Neuropathic Pain$500,578
R01 · FY2018 · NS
CB1 Allosteric Modulators: Molecular, Cellular and In Vivo Pharmacology$489,316
R01 · FY2018 · DA
S1P Receptor Mechanisms in Neuropathic Pain$411,286
R01 · FY2018 · NS
CB1 Allosteric Modulators: Molecular, Cellular and In Vivo Pharmacology$157,998
R01 · FY2018 · DA
Mutant Mouse/Viral Vector$142,737
P30 · FY2018 · DA · contact PI
CB1 Allosteric Modulators: Molecular, Cellular and In Vivo Pharmacology$498,694
R01 · FY2017 · DA
S1P Receptor Mechanisms in Neuropathic Pain$484,727
R01 · FY2017 · NS
Mutant Mouse/Viral Vector$142,738
P30 · FY2017 · DA · contact PI
CB1 Allosteric Modulators: Molecular, Cellular and In Vivo Pharmacology$533,900
R01 · FY2016 · DA
S1P Receptor Mechanisms in Neuropathic Pain$475,313
R01 · FY2016 · NS
Mutant Mouse/Viral Vector$141,309
P30 · FY2016 · DA · contact PI
S1P Receptor Mechanisms in Neuropathic Pain$396,661
R01 · FY2015 · NS
Mutant Mouse/Viral Vector$140,597
P30 · FY2015 · DA · contact PI
Monoacylglycerol Lipase Inhibitors for Treating Opioid Use Disorders$480,350
R01 · FY2014 · DA
Mutant Mouse/Viral Vector$152,394
P30 · FY2014 · DA · contact PI
Monoacylglycerol Lipase Inhibitors for Treating Opioid Use Disorders (JW)$73,188
R01 · FY2014 · DA
Monoacylglycerol Lipase Inhibitors for Treating Opioid Use Disorders (RO)$41,610
R01 · FY2014 · DA
Endogenous Cannabinoids and Brain Function$1,050,460
P01 · FY2013 · DA · contact PI
Monoacylglycerol Lipase Inhibitors for Treating Opioid Use Disorders$443,581
R01 · FY2013 · DA
Project 1$253,115
P01 · FY2013 · DA · contact PI
Targeting FAAH to treat Alzheimers disease$176,597
R21 · FY2013 · AG · contact PI
In Vivo Studies of Endocannabinoid Metabolizing Enzymes: Pain and Cognition$161,483
P01 · FY2013 · DA · contact PI
Core$105,224
P01 · FY2013 · DA · contact PI
Monoacylglycerol Lipase Inhibitors for Treating Opioid Use Disorders$33,950
R01 · FY2013 · DA
Endogenous Cannabinoids and Brain Function$1,095,009
P01 · FY2012 · DA · contact PI
Monoacylglycerol Lipase Inhibitors for Treating Opioid Use Disorders$419,934
R01 · FY2012 · DA
Project 1$285,127
P01 · FY2012 · DA · contact PI
In Vivo Studies of Endocannabinoid Metabolizing Enzymes: Pain and Cognition$178,845
P01 · FY2012 · DA · contact PI
Core$128,944
P01 · FY2012 · DA · contact PI
Endogenous Cannabinoids and Brain Function$1,095,673
P01 · FY2011 · DA · contact PI
Project 1$310,782
P01 · FY2011 · DA · contact PI
In Vivo Studies of Endocannabinoid Metabolizing Enzymes: Pain and Cognition$173,246
P01 · FY2011 · DA · contact PI
Core$140,546
P01 · FY2011 · DA · contact PI
Endogenous Cannabinoids and Brain Function$1,085,698
P01 · FY2010 · DA · contact PI
Project 1$307,952
P01 · FY2010 · DA · contact PI
In Vivo Studies of Endocannabinoid Metabolizing Enzymes: Pain and Cognition$181,863
P01 · FY2010 · DA · contact PI
Core$139,269
P01 · FY2010 · DA · contact PI
Project 1$326,590
P01 · FY2009 · DA
In Vivo Studies of Endocannabinoid Metabolizing Enzymes: Pain and Cognition$170,050
P01 · FY2009 · DA · contact PI
Core$136,500
P01 · FY2009 · DA
IN VIVO INHIBITION STUDIES OF FAAH$339,590
P01 · FY2008 · DA · contact PI
Endocannabinoid modulation of memory$278,765
R01 · FY2008 · DA · contact PI
Inhalation of Drugs of Abuse$209,073
R01 · FY2008 · DA · contact PI
IN VIVO INHIBITION STUDIES OF FAAH$330,997
P01 · FY2007 · DA · contact PI
Endocannabinoid modulation of memory$284,454
R01 · FY2007 · DA · contact PI
IN VIVO INHIBITION STUDIES OF FAAH$338,919
P01 · FY2006 · DA · contact PI
Endocannabinoid modulation of memory$292,950
R01 · FY2006 · DA · contact PI
IN VIVO INHIBITION STUDIES OF FAAH$329,051
P01 · FY2005 · DA
Endocannabinoid modulation of memory$300,000
R01 · FY2005 · DA
Endocannabinoid modulation of memory$300,000
R01 · FY2004 · DA
IN VIVO INHIBITION STUDIES OF FAAH$267,377
P01 · FY2004 · DA
THE HIGH SCHOOL ENRICHMENT MENTORSHIP PROGRAM$56,970
R25 · FY2000 · RR